A high a-v junctional pacemaker là gì năm 2024

Cardiac rhythms arising from the atrioventricular (AV) junction occur as an automatic tachycardia or as an escape mechanism during periods of significant bradycardia with rates slower than the intrinsic junctional pacemaker.

The AV node (AVN) has intrinsic automaticity that allows it to initiate and depolarize the myocardium during periods of significant sinus bradycardia or complete heart block. This escape mechanism, with a rate of 40-60 beats per minute, produces a narrow QRS complex because the ventricle is depolarized using the normal conduction pathway. An accelerated junctional rhythm (rate >60) is a narrow complex rhythm that often supersedes a clinically bradycardic sinus node rate (see images below). The QRS complexes are uniform in shape, and evidence of retrograde P wave activation may or may not be present.

A high a-v junctional pacemaker là gì năm 2024
Junctional bradycardia due to profound sinus node dysfunction. No atrial activity is apparent.

A high a-v junctional pacemaker là gì năm 2024
Note the retrograde P waves that precede each QRS complex.

Less commonly, the AV junction develops abnormal automaticity and exceeds the sinus node rate at a time when the sinus rate would be normal (see image below). These junctional tachycardias are most often observed in the setting of digitalis toxicity, recent cardiac surgery, acute myocardial infarction, or isoproterenol infusion.

A high a-v junctional pacemaker là gì năm 2024
Accelerated junctional rhythm is present in this patient. Note the inverted P waves that precede each QRS complex, with a rate of 115 bpm.

See Can't-Miss ECG Findings, Life-Threatening Conditions: Slideshow, a Critical Images slideshow, to help recognize the conditions shown in various tracings.

Pathophysiology

The junctional rhythm initiates within the AV nodal tissue. Accelerated junctional rhythm is a result of enhanced automaticity of the AVN that supersedes the sinus node rate. During this rhythm, the AVN is firing faster than the sinus node, resulting in a regular narrow complex rhythm. These rhythms may demonstrate retrograde P waves on ECG findings, and the rates can vary from 40-60 beats per minute.

Changes in autonomic tone or the presence of sinus node disease that is causing an inappropriate slowing of the sinus node may exacerbate this rhythm. Young healthy individuals, especially those with increased vagal tone during sleep, are often noted to have periods of junctional rhythm that is completely benign, not requiring any intervention.

Rarely, the AVN develops enhanced automaticity and overtakes a "normal" sinus node. This occasionally is observed in digitalis toxicity, following cardiac surgery (typically valve replacement), during acute myocardial infarction, or during isoproterenol infusion. Alteration in calcium metabolism in the sarcoplasmic reticulum causes accelerated junctional rhythm. [1]

Etiology

Causes of junctional rhythm include the following:

  • Digoxin toxicity
  • Ischemia of the AVN, especially with acute inferior infarction involving the posterior descending artery, the origin of the AV nodal artery branch.
  • Acutely after cardiac surgery, especially in children within 4 days after surgery for congenital cardiac defects; a literature review by Cools and Missant indicated that in patients undergoing surgery for congenital heart disease, the risk of junctional ectopic tachycardia is increased by surgery near the AV node, cardiopulmonary bypass operative time of over 90 minutes, young age, the use of inotropic drugs, and hypomagnesemia [2]
  • Diphtheria
  • Other drugs (eg, beta-blockers, calcium blockers, most antiarrhythmic agents) that cause sinus bradycardia
  • Metabolic states with increased adrenergic tone
  • Isoproterenol infusion

Epidemiology

United States information

Junctional rhythms are common in patients with sick sinus syndrome or in patients who have significant bradycardia that allows the AV nodal region to determine the heart rate.

Junctional escape rhythms, which are common in younger and/or athletic individuals during periods of increased vagal tone (eg, sleep), occur equally in males and females.

This rhythm may occur in persons of any age.

Junctional rhythms during sleep are common in children and in athletic adults.

Prognosis

No evidence suggests increased mortality. Prognosis is good.

Morbidity/mortality

The heart rate during a junctional rhythm often determines whether the patient has symptoms.

Presence of AV dissociation can lead to symptoms in patients because of atrial conduction and subsequent contraction when the tricuspid valve is closed (ie, canon a waves).

Periods of junctional rhythm are not necessarily associated with an increase in mortality. If an obvious cause is present, such as complete heart block or sick sinus syndrome, then the morbidity or mortality is directly related to that and not to the junctional rhythm mechanism, which is serving as a "backup rhythm" during the periods of bradycardia. Accelerated junctional rhythms may be a sign of digitalis toxicity.

Complications

Complications of junctional rhythm are usually limited to symptoms such as dizziness, dyspnea, or presyncope.

Accidental injury may result from syncope if the arrhythmia is not tolerated well.

Exacerbation of cardiac comorbidities, such as congestive heart failure and rate-related cardiac ischemia, may occur.

  1. Kim D, Shinohara T, Joung B, et al. Calcium dynamics and the mechanisms of atrioventricular junctional rhythm. J Am Coll Cardiol. 2010 Aug 31. 56(10):805-12. [QxMD MEDLINE Link].
  2. Cools E, Missant C. Junctional ectopic tachycardia after congenital heart surgery. Acta Anaesthesiol Belg. 2014. 65(1):1-8. [QxMD MEDLINE Link].
  3. Deal BJ, Wolff GS, Gelband H. Current Concepts in Diagnosis and Management of Arrhythmias in Infants and Children. New York, NY: Futura Publishing; 1998. 73-5.
  4. Josephson ME. Clinical Cardiac Electrophysiology. 4th ed. Baltimore, Md: Williams & Wilkins; 2008.
  5. Libby P, Bonow RO, Mann DL, Zipes, DP. Specific arrhythmias: diagnosis and treatment. Braunwald E, ed. Heart Disease: A Textbook of Cardiovascular Medicine. 8th ed. Philadelphia, Pa: WB Saunders; 2007. 640-5.
  6. Tuohy S, Saliba W, Pai M, Tchou P. Catheter ablation as a treatment of atrioventricular block. Heart Rhythm. 2018 Jan. 15(1):90-6. [QxMD MEDLINE Link].
  7. Daubert JP, Rosero SZ, Corsello A. Tachycardias. Rakel RE, Bope ET, eds. Conn's Current Therapy. New York, NY: WB Saunders; 2001. 286-95.
  8. Di Biase L, Gianni C, Bagliani G, Padeletti L. Arrhythmias involving the atrioventricular junction. Card Electrophysiol Clin. 2017 Sep. 9(3):435-52. [QxMD MEDLINE Link].
  9. Seino Y, Sato N, Fukui K, Ishikawa J, Nakagawa M, Nomura T. Transient systolic anterior motion with junctional rhythm after mitral valve repair in the intensive care unit. Crit Ultrasound J. 2018 Nov 12. 10(1):30. [QxMD MEDLINE Link]. [Full Text].
  10. Ban JE. Neonatal arrhythmias: diagnosis, treatment, and clinical outcome. Korean J Pediatr. 2017 Nov. 60(11):344-52. [QxMD MEDLINE Link]. [Full Text].
  • Junctional bradycardia due to profound sinus node dysfunction. No atrial activity is apparent.
  • Note the retrograde P waves that precede each QRS complex.
  • Accelerated junctional rhythm is present in this patient. Note the inverted P waves that precede each QRS complex, with a rate of 115 bpm.

A high a-v junctional pacemaker là gì năm 2024

A high a-v junctional pacemaker là gì năm 2024

Author

Sean C Beinart, MD, MSc, FACC, FHRS Electrophysiologist, Cardiac Associates, PC; Medical Director, Center for Cardiac and Vascular Research, Washington Adventist Hospital; Assistant Medical Director, Arrhythmia Service, Frederick Memorial Hospital

Sean C Beinart, MD, MSc, FACC, FHRS is a member of the following medical societies: Alpha Omega Alpha, American College of Cardiology, American College of Physicians, American Heart Association, American Medical Association, Heart Rhythm Society

Disclosure: Serve(d) as a speaker or a member of a speakers bureau for: Abbott; Medtronic.

Specialty Editor Board

Francisco Talavera, PharmD, PhD Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Received salary from Medscape for employment. for: Medscape.

Steven J Compton, MD, FACC, FACP, FHRS Director of Cardiac Electrophysiology, Alaska Heart Institute, Providence and Alaska Regional Hospitals

Steven J Compton, MD, FACC, FACP, FHRS is a member of the following medical societies: American College of Physicians, American Heart Association, American Medical Association, Heart Rhythm Society, Alaska State Medical Association, American College of Cardiology

Disclosure: Nothing to disclose.

Chief Editor

Mikhael F El-Chami, MD Associate Professor, Department of Medicine, Division of Cardiology, Section of Electrophysiology, Emory University School of Medicine

Mikhael F El-Chami, MD is a member of the following medical societies: Alpha Omega Alpha, American College of Cardiology, American Heart Association, Heart Rhythm Society

Disclosure: Serve(d) as a director, officer, partner, employee, advisor, consultant or trustee for: Medtronic; Boston Scientific, Biotronik
Received research grants (as part of Multicenter studies) from Medtronic and Boston Scientific.

Acknowledgements

The authors and editors of Medscape Reference gratefully acknowledge the contributions of previous authors Jonathan Langberg, MD; Spencer Rosero, MD; Wojciech Zareba, MD, PhD, FACC; and David Huang, MD to the development and writing of this article.